ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE

Glenmark Pharmaceuticals Inc., USA🇺🇸 United States

FDA Page

Effective Date: May 31, 2021
Approval ID: 467d6ce3-bc05-4aa1-87cc-3214fd628d39
Products: 1 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN and EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral useInitial U.S. Approval: 1999

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.